Flourimetric analysis of hydrogen peroxide with automated measurement

Clinical Laboratory

Volumn 49, Issue 11-12, 2003, Pages 637-643

  van Beurden, Wendy J C ^a,c   Van den Bosch, Maria J A ^a   Janssen, Willie ^a   Smeenk, Frank W J M ^a   Dekhuijzen, P N Richard ^b   Harff, Gottfried A ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Automated injection; Exhaled breath condensate; Fluorimetric analysis; Hydrogen peroxide; Oxidated stress

Indexed keywords

4 HYDROXYPHENYLACETIC ACID; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREATH ANALYSIS; CALIBRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FLOW INJECTION ANALYSIS; FLOW RATE; FLUORESCENCE ANALYSIS; FLUOROMETRY; HUMAN; LABORATORY AUTOMATION; MALE; MEASUREMENT; REFERENCE VALUE; REPRODUCIBILITY; SAMPLER; SENSITIVITY ANALYSIS; STANDARD; STATISTICAL SIGNIFICANCE;

ARMORACIA RUSTICANA;

EID: 0345601779     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 163: 1256-1276
2. American Thoracic Society. Definitions, epidemiology, pathophysiology, diagnosis and staging. Am J Respir Crit Care Med 1995; 152:S78-?
3. Barnes PJ. Chronic Obstructive Pulmonary Disease. New Engl J Med 2000; 343: 269-280
4. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304-1309
5. Repine JE, Bast A, Lankhorst I, The Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-357
6. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722
7. Guilbault GG, Brignac PJ, Juneau M. New substrates for the fluorimetric determination of oxidative enzymes. Anal Chem 1968; 40: 1256-1263
8. Hyslop PA, Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation process. Anal Biochem 1984; 141: 280-286
9. Dohlman WA, Black HR, Royall JA. Expired hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993; 148: 955-960
10. Jobsis Q, Raatgreep HC, Hermans PWM, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997; 10: 519-521
11. Worlitzsch D, Herberth G, Ulrich M, Doring G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998; 11: 377-383
12. Dekhuijzen PNR, Aben KKH, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 145: 813-816
13. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93: 389-396
14. Sznajder JI, Fraiman A, Hall JB, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612
15. Loukides S, Horvath I, Wodehouse T, Cole PJ, Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998; 158: 991-994
16. Kietzmann D, Kahl R, Muller M, Burchardi R, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19: 78-81
17. Antczak A, Nowak D, Shariati B, Krol M, Piasecka G, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10: 1235-1241
18. Ho LP, Faccenda J, Innes JA, Greening AP. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999; 13: 103-106
19. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LH, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1: 11-14
20. Beurden van WJC, Harff GA, Dekhuijzen PNR, van den Bosch MJA, Creemers JPHM, Smeenk FWJM. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respiration 2002; 96: 197-203
21. Beurden van WJC, Dekhuijzen PNR, Harff GA, Smeenk FWJM. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002; 69: 211-216
22. 2 and thiobarbituric acid reactive substances (TBARS) by healthy subjects. Free Rad Biol Med 2001; 30: 178-186
23. Schleiss MB, Holz O, Behnke M, Richter K, Magnussen H, Jorres RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 1115-1118
24. Siafakas NM, Vermeire P, Pride NB. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420